Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Clover Health Investments (CLOV) stock in plain English

Free brief · no signupStart here
CLOVPublished Nov 15, 2026
Clover Health Investments Corp
Healthcare · Healthcare Plans
Sells Medicare Advantage health insurance plans to seniors in select American states. Provides clinical workflow software to network physicians to monitor chronic conditions.
Assets:
Clover AssistantProprietary software used by network physicians during visits
80,000+ membersMedicare Advantage lives under active insurance coverage
New Jersey footprintPrimary operating market representing the majority of membership
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

65
OPS ScoreOperating finances
Latest quote
-9.59%$3.77
$2.00B
199.5×
$2.74B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 15, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was CLOV. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Clover Health Investments (CLOV) do?

Clover Health Investments Corp (CLOV) is a U.S.-listed company in Healthcare (Healthcare Plans). What it does: Sells Medicare Advantage health insurance plans to seniors in select American states. Provides clinical workflow software to network physicians to monitor chronic conditions. Integrates proprietary diagnostic software into primary care workflows to manage Medicare Advantage patient health. It is worth $2.00B on the market and sold $2.74B over the last year.

Market cap
$2.00B
P/E ratio
199.5×
Annual sales
$2.74B
Sector
Healthcare
Industry
Healthcare Plans
Brief updated
Nov 15, 2026

Brands and businesses behind CLOV

  • Counterpart Health: Licenses clinical management software to external healthcare organizations to generate recurring technology fees.

CLOV’s flags, in plain English

Each flag is a number from Clover Health Investments’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.

Low debt

Low debt, only 0% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Earnings Jumping

Profits up 66.8% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.

Growth vs Price

The price looks reasonable for how fast it is growing. The price looks reasonable for how fast its profits are growing.

Priced for Perfection

Priced at 199.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about CLOV

How big is Clover Health Investments?

Clover Health Investments’ market cap is $2.00B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.74B: what customers paid the company over the last year, before any costs.

What is CLOV’s P/E ratio?

CLOV’s P/E ratio is 199.5×. Investors pay about 199.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with CLOV?

Federal regulators determine Medicare Advantage reimbursement formulas and Star Ratings that heavily dictate annual revenue. That is one risk on Clover Health Investments’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Clover Health Investments’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. CLOV’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card